Adherence to oral anticancer chemotherapies and estimation of the economic burden associated with unused medicines-Reference-Cited by-同舟云学术

Adherence to oral anticancer chemotherapies and estimation of the economic burden associated with unused medicines

Published:2020-08-28 Issue:5 Volume:42 Page:1311-1318
ISSN:2210-7703
Container-title:International Journal of Clinical Pharmacy
language:en
Short-container-title:Int J Clin Pharm

Author:

Matti Nazish,Delon Claire,Rybarczyk-Vigouret Marie-Christine,Khan Gul Majid,Beck Morgane,Michel Bruno^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology,Toxicology,Pharmacy

Link

https://link.springer.com/content/pdf/10.1007/s11096-020-01083-4.pdf

Reference52 articles.

1. Henry D, Taylor C. Pharmacoeconomics of cancer therapies: considerations with the introduction of biosimilars. Semin Oncol. 2014;41(3):S13–20.

2. Cancer-World Health Organization. 2018. https://www.who.int/cancer/PRGlobocanFinal.pdf. Accessed 14 Oct 2019.

3. Bossi P, Alfieri S. The benefit of a multidisciplinary approach to the patient treated with (chemo) radiation for head and neck cancer. Curr Treat Options Oncol. 2016;17(10):53.

4. Fujii M. Recent multidisciplinary approach with molecular targeted drugs for advanced head and neck cancer. Int J Clin Oncol. 2014;19(2):220–9.

5. Lindgren P, Jönsson B, Hofmarcher T et al. Comparator report on patient access to cancer medicines in Europe revisited. 2016. https://www.efpia.eu/media/412110/ihe-report-2016_4_.pdf. Accessed 14 Oct 2019.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Redispensing of expensive oral anticancer medicines: A practical application;Journal of Oncology Pharmacy Practice;2023-05-16

2. Effects of an out-of-pocket maximum in Medicare Part D;The American Journal of Managed Care;2022-02-07

3. Key factors underlying the willingness of patients with cancer to participate in medication redispensing;Research in Social and Administrative Pharmacy;2021-12

4. Unused oral anticancer drugs costly in France;PharmacoEconomics & Outcomes News;2020-09